Brookline, MA, United States of America

Aleksandar Rajlic

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Tesaro, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aleksandar Rajlic. Retrieved from https://idiyas.com/inventor/aleksandar-rajlic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Aleksandar Rajlic

Introduction

Aleksandar Rajlic is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly with his work on formulations of the compound niraparib. His innovative approach has led to advancements in oral administration methods for this important active pharmaceutical ingredient.

Latest Patents

Rajlic holds 1 patent related to his work on niraparib formulations. The patent describes pharmaceutical tablet compositions that are suitable for oral administration. It also outlines methods for preparing these tablet compositions, which are designed to treat various disorders and conditions effectively.

Career Highlights

Aleksandar Rajlic is currently associated with Tesaro, Inc., a company known for its focus on innovative cancer therapies. His work at Tesaro has allowed him to contribute to the development of groundbreaking treatments that can improve patient outcomes.

Collaborations

Throughout his career, Rajlic has collaborated with esteemed colleagues such as Simon McGurk and Padma Narayan. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Aleksandar Rajlic's contributions to pharmaceutical innovations, particularly in the formulation of niraparib, highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…